Molecular and clinicopathologic characteristics of HER2-mutant lung adenocarcinoma (ADC).

10596 Background: Activating mutations within the tyrosine kinase domain of HER2 have been reported in a small subset of lung ADCs. HER2 mutations are mutually exclusive with EGFR and KRAS mutation...